pulseData, a New York City-based healthcare data science company focused on predictive algorithms for Chronic Kidney Disease and other chronic diseases, raised $16.5m in Series A funding.
The round was led by Bain Capital Private Equity and Two Bear Capital, with participation from Alumni Ventures Group and existing investors.
The company intends to use the funds to expand operations and its business reach.
Led by Hai Po Sun, Co-Founder and CTO, and Teddy Cha, Co-Founder and CEO, pulseData is building a suite of artificial intelligence solutions which predict the progression of chronic kidney disease and cardiorenal comorbidities.
Customers include Medicare Advantage plans, Commercial health plans, self-insured employers, risk-bearing health systems, Accountable Care Organizations, and providers participating in value-based care.